Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2021 08:00 ET | Source: Quanta, Inc.

Medolife Rx Breaks Ground on Lab Facility and Increases Scorpion Count at First-of-Its-Kind Reservation in the Dominican Republic

BURBANK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 20, 2021 08:00 ET | Source: Quanta, Inc.

Medolife Rx Announces Pre-Clinical Results on Escozine Showing Synergistic Effect in Killing Cancer Cells When Combined With Chemotherapy Agents

BURBANK, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 19, 2021 11:48 ET | Source: Quanta, Inc.

Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations

BURBANK, CA, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 15, 2021 08:30 ET | Source: Quanta, Inc.

Medolife Rx to Present at The 2021 Sequire Cannabis Conference on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST

BURBANK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 13, 2021 08:30 ET | Source: Quanta, Inc.

Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate

BURBANK, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 08, 2021 08:30 ET | Source: Quanta, Inc.

Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate

BURBANK, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 06, 2021 08:30 ET | Source: Quanta, Inc.

Medolife Rx Receives Significant Purchase Order of Immunapen, Its Easy-to-Use Nutraceutical Product Designed to Increase Quality of Life and Support a Healthy Immune System

BURBANK, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
April 01, 2021 09:00 ET | Source: Quanta, Inc.

Medolife Rx’s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic

BURBANK, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
March 30, 2021 09:00 ET | Source: Quanta, Inc.

Medolife Rx Furthers Expansion of Scorpion Reservation; Prepares for Mass Production of Escozine Required Upon Product Registration

BURBANK, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
March 25, 2021 09:00 ET | Source: Quanta, Inc.

Medolife Rx Completes Batch Production of Escozine® for FDA Submission

BURBANK, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right